Tim K. Mackey,Gaurvika Nayyar
Abstract:INTRODUCTION: The globalization of the pharmaceutical supply chain has introduced new challenges, chief among them, fighting the international criminal trade in fake medicines. As the manufacture, supply, and distribution of drugs becomes more complex, so does the need for innovative technology-based solutions to protect patients globally. Areas covered: We conducted a multidisciplinary review of the science/health, information technology, computer science, and general academic literature with the aim of identifying cutting-edge existing and emerging 'digital' solutions to combat fake medicines. Our review identified five distinct categories of technology including mobile, radio frequency identification, advanced computational methods, online verification, and blockchain technology. Expert opinion: Digital fake medicine solutions are unifying platforms that integrate different types of anti-counterfeiting technologies as complementary solutions, improve information sharing and data collection, and are designed to overcome existing barriers of adoption and implementation. Investment in this next generation technology is essential to ensure the future security and integrity of the global drug supply chain.
What problem does this paper attempt to address?
This paper aims to address the problem of the global counterfeit drug trade. Specifically, with the globalization of the pharmaceutical supply chain, the manufacturing, supply, and distribution of counterfeit drugs have become increasingly complex, which poses a serious threat to patient safety and has a negative impact on public health. To meet this challenge, this paper identifies existing and emerging digital technology solutions through a multidisciplinary literature review, which can be used to combat the global counterfeit drug trade.
### Main problems the paper attempts to solve:
1. **Threats to public health and patient safety from the global counterfeit drug trade**: Counterfeit drugs not only endanger patients' lives and safety, but also lead to poor treatment outcomes, waste of medical resources, decreased trust in drug brands, and reduced economic output.
2. **New challenges brought about by the globalization of the pharmaceutical supply chain**: With the globalization of the pharmaceutical supply chain, the manufacturing, supply, and distribution of drugs have become more complex, increasing the risk of counterfeit drugs infiltrating the supply chain.
3. **Inadequacies of existing anti - counterfeit drug measures**: Traditional anti - counterfeit drug measures such as serialization, authentication, and tracking technologies are effective, but more advanced digital technologies are required to improve their performance and management capabilities.
4. **New channels brought about by the rise of the Internet and e - commerce platforms**: The popularization of the Internet and e - commerce platforms has provided new channels for the sale of counterfeit drugs. In particular, the large number of illegal online pharmacies has further aggravated the counterfeit drug problem.
### Main contributions of the paper:
- **Identifying existing and emerging digital technologies**: Through a multidisciplinary literature review, the paper identifies five main types of digital technologies, including mobile technology, radio - frequency identification (RFID), advanced computing methods, online verification, and blockchain technology.
- **Evaluating the maturity and application prospects of technologies**: The paper analyzes in detail the maturity, practical application cases, and future development potential of these technologies.
- **Proposing comprehensive solutions**: The paper suggests integrating different anti - counterfeit drug technologies into a unified platform to improve information sharing and data collection capabilities and overcome the barriers to the adoption and implementation of existing technologies.
Through these efforts, the paper hopes to provide innovative digital technology solutions for the international community to protect the drug safety of patients worldwide.